196 related articles for article (PubMed ID: 9578164)
1. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Krcmery V; Oravcova E; Spanik S; Mrazova-Studena M; Trupl J; Kunova A; Stopkova-Grey K; Kukuckova E; Krupova I; Demitrovicova A; Kralovicova K
J Antimicrob Chemother; 1998 Mar; 41(3):373-80. PubMed ID: 9578164
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Krcmery V; Mrazova M; Kunova A; Grey E; Mardiak J; Jurga L; Sabo A; Sufliarsky J; Sevcikova L; Sorkovska D; West D; Trupl J; Novotny J; Mateicka F
Support Care Cancer; 1999 Nov; 7(6):428-31. PubMed ID: 10541986
[TBL] [Abstract][Full Text] [Related]
3. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol.
Krcmery V; Mateicka F; Kunová A; Spánik S; Gyarfás J; Sycová Z; Trupl J
Support Care Cancer; 1999 Jan; 7(1):39-43. PubMed ID: 9926973
[TBL] [Abstract][Full Text] [Related]
4. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
5. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
Krcmery V; Huttova M; Mateicka F; Laho L; Jurga L; Ondrusova A; Tarekova Z; Kralinsky K; Hanzen J; Liskova A; Mrazova M; Sabo A; Pisarcikova M; Kovacicova G; Chovancova D; Szovenyiova Z
J Antimicrob Chemother; 2001 Oct; 48(4):521-5. PubMed ID: 11581231
[TBL] [Abstract][Full Text] [Related]
8. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia.
Krcmery V; Laho L; Huttova M; Ondrusova A; Kralinsky K; Pevalova L; Dluholucky S; PISARCuÍKOVÁ M; Hanzen J; Filka J; Sejnová D; Lišková A; Purgelová A; Szovenyová Z; Koren P
J Med Microbiol; 2002 Feb; 51(2):110-116. PubMed ID: 11863261
[TBL] [Abstract][Full Text] [Related]
9. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
[TBL] [Abstract][Full Text] [Related]
10. Prospective study of fungaemia in a single cancer institution over a 10-y period: aetiology, risk factors, consumption of antifungals and outcome in 140 patients.
Kovacicová G; Spánik S; Kunová A; Trupl J; Sabo A; Koren P; Sulcová M; Mateicka F; Novotný J; Pichnová E; Jurga L; Chmelík B; Obertik T; West D; Krcéry V
Scand J Infect Dis; 2001; 33(5):367-74. PubMed ID: 11440223
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Bodey GP; Mardani M; Hanna HA; Boktour M; Abbas J; Girgawy E; Hachem RY; Kontoyiannis DP; Raad II
Am J Med; 2002 Apr; 112(5):380-5. PubMed ID: 11904112
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
Krcmery V; Spanik S; Kunova A; Trupl J; Grausova S; Krupova I; Mateicka F; Pichnova E; Grey E; Sabo A
J Chemother; 1999 Apr; 11(2):131-6. PubMed ID: 10326744
[TBL] [Abstract][Full Text] [Related]
13. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.
Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L
J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
[TBL] [Abstract][Full Text] [Related]
17. Trends and sources of nosocomial fungaemia.
Taylor GD; Buchanan-Chell M; Kirkland T; McKenzie M; Wiens R
Mycoses; 1994; 37(5-6):187-90. PubMed ID: 7898515
[TBL] [Abstract][Full Text] [Related]
18. Persistent fungemia--risk factors and outcome in 40 episodes.
Kovacicova G; Lovaszova M; Hanzen J; Roidova A; Mateicka F; Lesay M; Krcméry V
J Chemother; 2001 Aug; 13(4):429-33. PubMed ID: 11589487
[TBL] [Abstract][Full Text] [Related]
19. Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis.
Kunova A; Trupl J; Demitrovicova A; Jesenska Z; Grausova S; Grey E; Pichna P; Kralovicova K; Sorkovska D; Krupova I; Spanik S; Studena M; Koren P; Krcmery V
Microb Drug Resist; 1997; 3(3):283-7. PubMed ID: 9271000
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal 10-year prospective survey of fungaemia in Slovak Republic: trends in etiology in 310 episodes. Slovak Fungaemia study group.
Krcméry V; Kovacicová G
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):7-11. PubMed ID: 10744362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
